Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report

Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report

Abstract Background Combination therapy of interferon and ribavirin has traditionally been used to eradicate hepatitis C virus. The sustained virologic response achieved with interferon-related therapy is persistent, and late relapses after achieving sustained virologic response at 24 weeks using th...

Full description

Bibliographic Details
Main Authors: Ken Kurokawa, Takamasa Ohki, Jun Kato, Yukiyo Fukumura, Makoto Imai, Chikako Shibata, Junya Arai, Mayuko Kondo, Kaoru Takagi, Kentaro Kojima, Michiharu Seki, Masaya Mori, Nobuo Toda, Kazumi Tagawa
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Journal of Medical Case Reports
Subjects:
Late viral relapse
Sarcomatous change
Sustained virologic response at 24 weeks (SVR 24)
Online Access:http://link.springer.com/article/10.1186/s13256-020-02392-y

Internet

http://link.springer.com/article/10.1186/s13256-020-02392-y

Similar Items